1 – 10 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Emerging role of microRNAs as regulators of protein kinase C substrate MARCKS and MARCKSL1 in cancer
(
- Contribution to journal › Scientific review
- 2023
-
Mark
P90 ribosomal S6 kinases : A bona fide target for novel targeted anticancer therapies?
(
- Contribution to journal › Scientific review
-
Mark
Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling
(
- Contribution to journal › Article
-
Mark
Novel precision medicine approaches and treatment strategies in hematological malignancies
(
- Contribution to journal › Scientific review
-
Mark
Biomarkers or biotargets? Using competition to lure cancer cells into evolutionary traps
(
- Contribution to journal › Article
- 2022
-
Mark
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia : Results from the HEAT-AML trial
(
- Contribution to journal › Article
-
Mark
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
(
- Contribution to journal › Article
- 2021
-
Mark
The influence of domain permutations of an albumin-binding domain-fused her2-targeting affibody-based drug conjugate on tumor cell proliferation and therapy efficacy
(
- Contribution to journal › Article
-
Mark
Precision oncology of high-grade ovarian cancer defined through targeted sequencing
(
- Contribution to journal › Article
-
Mark
A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence
(
- Contribution to journal › Debate/Note/Editorial